World Bio-Informatics Market (2005-2010)

• Publication date: November 2005
• Report size: 85 pages

In the recent years, the continuously changing market of bioinformatics applications enjoys a wide acceptance owing to declining new drugs’ manufacturing, non existence of potential drugs and expiry of patents. In 2004-05, this market with a US $1.4 billion has been competing with unusual and innovative tools facilitating critical R&D for the bioinformatics companies. RNCOS, a market research organization has established a market researc...

In the recent years, the continuously changing market of bioinformatics applications enjoys a wide acceptance owing to declining new drugs’ manufacturing, non existence of potential drugs and expiry of patents. In 2004-05, this market with a US $1.4 billion has been competing with unusual and innovative tools facilitating critical R&D for the bioinformatics companies.

RNCOS, a market research organization has established a market research report namely “World Bio-Informatics Market (2005-2010)” which gives the latest information on new products and trends in the bioinformatics industry as also research, product development and investment pertaining to the market segments.

As it stands the bioinformatics market is at stability where 20% of the applications discovered are based on genomics and proteomics, which boosts growth of bioinformatics tools. A greater number of R&D centers across the world are seeking a common base for transfer of data, information and knowledge to enable an informatics-based decision support system. The market research report forecasts the bioinformatics market to provide an information processing system, assimilation of past developments and scope in future.

RNCOS analysts predict the product lines, software tools and other biometric applications to project an annual market growth of 15.8% or US $3 billion by 2010 higher by 14.5% in 2003. With this the bioinformatics companies could consolidate data, make analysis & useful management and disseminate tools to help drug companies to curtail cost and time.

Given the said market structure there is an emerging need to develop breakthrough drugs while shortening the discovery time and costs. There is also need for forming mergers and partnerships of companies both at local and international levels. Leading biotech firms like Compugen, DoubleTwist have come forward with novel drug programs. Interestingly, India and South East Asian countries have comparative advantage in terms of cheap labor, which can offer database solutions and genome research for biotech companies globally.

“World Bioinformatics Market (2005-2010)” gives an overview of the bioinformatics market segments and that they are poised for future growth. The market research report also elicits the unusual, critical and outstanding opportunities for expansion in the next five years itself.

REPORT HIGHLIGHTS:
The market research report particularly interested in the value added by bioinformatics to the process of drug discovery and development discuss various technologies and patenting trends in the industry.

This new market research report provides you with the most detailed and up-to-date analysis, news, developments, experts’ opinions and insight into the informatics market. The report includes chapters that provide:
1. Detailed analysis of the latest trends in bioinformatics.
2. In-depth profiles of 26 leading companies with informatics tools and technologies and its 5-year forecasts for the year 2005-2010.
3. Survey of industry experts’ views on informatics.
4. Potential of bio-informatics applications and market predictions of trends in US expenditure on IT solutions.
5. Projections for future applications in drug discovery, R&D and analysis of commercial business strategies.
6. Latest developments and comprehensive insight into bioinformatics business strategies.

The aim of this study was to analyze the possible growth opportunities for the bioinformatics industry. We are also interested in determining the current models employed for commercialization of bioinformatics and to examine the success of such models.

REPORT FEATURES/ WHO SHOULD BUY THIS?
The market research report “World Bio-Informatics Market (2005-2010)” compiles a study of economic environment, technological descriptions and bioinformatics applications which would be valuable for investors and companies engaged in gene therapy and molecular medicine. It essentially aims the pharmaceutical industry, biotechnology firms, research laboratories and those interested in the commercial opportunities in this field.

The report compiles nine chapters where chapters 2 & 3 give introduction to bioinformatics and, rules and regulations framework of the industry respectively. Chapter 4 deals with the global bioinformatics industry as per technology and market analysis of 2005. Chapter 5 provides the nanotechnology aspect of bioinformatics industry; chapter 6 gives the market opportunities and challenges; chapter 7 gives product innovations and launches like Super Server, Experiment Design Automation, new tools for genomic and proteomic research, SYBYL Molecular Modeling Suite 7.1, Open Integration Platform, SciTegic launches, TCS Bioinformatics software, Rosetta Biosoftware, Sigma-Aldrich launches, Ciphergen’s new Equalizer technology and so on. Chapter 8 talks about recent issues and current developments. Finally chapter 9 gives company profiles of key players.

Global Nanotechnology Industry

1. Executive Summary
2. Introduction to Bioinformatics
3. Rules and Regulations Framework of the Bioinformatics Industry
4. Global Bioinformatics Industry—Technology and Market Analysis, 2005
4.1. Total Bioinformatics Market, ($ Millions), 2005
4.2. Bioinformatics Market, By Geographical Segmentation, (%) 2005
4.2.1. US and Canada
4.2.2. Europe
4.2.3. Asia-Pacific
4.3. Bioinformatics Market, By Application Areas, (%) 2005
4.3.1. Pharmacogenomics
4.3.2. Proteomics
4.3.3. Genomics
4.3.4. Drug Discovery
4.4. Bioinformatics Market, By IT Tools, (%) 2005
4.5. Investment Opportunities From Biotech companies and Venture Capitalists, (%) 2005
4.6. Employment Opportunities, (%) 2005
4.7. Future Forecast of Bioinformatics Market, 2010
5. Nanotechnology in Bioinformatics Industry
6. Market Opportunities and Challenges for Bioinformatics
7. Product Innovations and Launches
7.1. Super Server for Bioinformatics Developed
7.2. Experiment Design Automation (XDA) Software Provides Success to Bioinformatics Leaders
7.3. New Tools For Genomic And Proteomic Research
7.4. GeneDirector® and GeneSight® Achieves GeneChip-compatible™ Status
7.5. Benchware Notebook and Benchware Dock Launched for Real-Time Virtual-Screening Analyses
7.6. SYBYL Molecular Modeling Suite 7.1 Version Released — Includes Innovative New Products and Numerous Enhancements
7.7. Deployment of Industry-Leading Enterprise Chemical Informatics System at Schering AG
7.8. Open Integration Platform Launched by Accelrys technology to Enable Customers to Construct Tailored Solutions
7.9. SciTegic Launches New Sequence Analysis Collection
7.10. TCS Develops Bioinformatics Software on Linux Platform
7.11. Rosetta Biosoftware and Agendia to Deliver Diagnostic Utilities
7.12. Gene-IT Unveils Sequence-Centric Data Integration Approach to Overcome Challenges of Genome-Scale Research
7.13. Computers Make Big Strides in Predicting Protein Structure
7.14. Sigma-Aldrich Launches Functional Cancer Protein Microarray
7.15. Ciphergen's New Equalizer(TM) Technology Enables the Detection of Low Abundance Proteins
8. Recent Issues and Current Developments—News Digest
9. Company Profiles of Key Players
9.1. Accelrys Inc.
9.2. ACLARA BioSciences Inc.
9.3. Ariadne Genomics
9.4. Affymetrix
9.5. Agilent Technologies
9.6. Amersham Biosciences Limited
9.7. Applied Biosystems Group
9.8. BioDiscovery Inc.
9.9. Celera Genomics Corporation
9.10. Cengent Therapeutics Inc.
9.11. Ciphergen Biosystems Inc.
9.12. Compugen Limited
9.13. Curagen
9.14. Gene Logic
9.15. GeneMachines Inc.
9.16. Geospiza
9.17. IBM Life Sciences
9.18. Illumina Inc.
9.19. InforMax Inc.
9.20. Incyte Corporation
9.21. Lion Bioscience AG
9.22. Silicon Graphics
9.23. Spotfire, Inc.
9.24. Tripos Inc.
9.25. Xanthon Inc.
9.26. Zyomyx Inc.

List of Figures:
Figure 1. Worldwide Value of Bioinformatics Market, ($ Millions) 2002-2005 and 2010
Figure 2. Worldwide Value of Bioinformatics Market by Product Categories, ($ Millions) 2002-2005 and 2010
Figure 3. Worldwide Bio-IT Infrastructure Market forecast, by Sector, (%) 2002-2007
Figure 4. Bioinformatics Equipment/Bio-Tools Market, (%) 2000-2005
Figure 5. Global Market For Nanotechnology Applications in Bioinformatics, by Technology Type, ($ Millions) 2004-2010
Figure 6. Global Drug Discovery Spending, ($ billion) 2002-2006
Figure 7. Worldwide Sales of Bioinformatics Software and Data, ($ million) 2000-2010
Figure 8. Worldwide Bioinformatics Market, by Segments, ($ billion) 2005
Figure 9. Biotech Companies Investment Ratio, (%) 1999-2005
Figure 10. Venture Capitalist Investment Ratio, (%) 1999-2005
Figure 11. World Pharmacogenomics Market, ($million) 2005
Figure 12. World Proteomics Market, (%) 2005
Figure 13. World Genomics Market, (%) 2005
Figure 14. Global Market for Genomics-based Technologies Used in Drug Target Screening, Identification and Validation, (%) 2001, 2002 and 2007